Compounds > alpha-naphthoflavone
Page last updated: 2024-08-21

alpha-naphthoflavone and docetaxel anhydrous

alpha-naphthoflavone has been researched along with docetaxel anhydrous in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Cao, C; Chen, W; Hu, J; Shi, Y; Wang, L; Ye, W; Zhou, L; Zhou, W1
Beloglazkina, EK; Ber, AP; Borisova, YA; Chepikova, OE; Erofeev, A; Gorelkin, P; Khazanova, ES; Khudyakov, AD; Kolmogorov, VS; Kovalev, S; Machulkin, AE; Majouga, AG; Nimenko, EA; Pankratov, AA; Petrov, SA; Plotnikova, EA; Pokrovsky, VS; Polshakov, VI; Shafikov, RR; Skvortsov, DA; Smirnova, GB; Uspenskaya, AA; Vaneev, AN; Zamyatnin, AA; Zyk, NU; Zyk, NV1
Bournique, B; Lemarié, A1
Cui, J; Cui, Q; Li, S; Meng, Q; Zhang, X; Zhou, W1

Other Studies

4 other study(ies) available for alpha-naphthoflavone and docetaxel anhydrous

ArticleYear
Design and synthesis of α-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation.
    European journal of medicinal chemistry, 2020, Mar-01, Volume: 189

    Topics: Benzoflavones; Cell Line, Tumor; Cytochrome P-450 CYP1B1; Docetaxel; Drug Design; Drug Resistance, Neoplasm; Humans; Proteolysis; Thalidomide

2020
Synthesis, Characterization, and Preclinical Evaluation of a Small-Molecule Prostate-Specific Membrane Antigen-Targeted Monomethyl Auristatin E Conjugate.
    Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23

    Topics: Antigens, Surface; Cell Line, Tumor; Coordination Complexes; Glutamate Carboxypeptidase II; Humans; Male; Microsomes, Liver; Oligopeptides; Prostatic Neoplasms; Reactive Oxygen Species; Xenograft Model Antitumor Assays

2021
Docetaxel (Taxotere) is not metabolized by recombinant human CYP1B1 in vitro, but acts as an effector of this isozyme.
    Drug metabolism and disposition: the biological fate of chemicals, 2002, Volume: 30, Issue:11

    Topics: Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Benzoflavones; Catalysis; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Docetaxel; Estradiol; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Paclitaxel; Recombinant Proteins; Spectrometry, Fluorescence; Taxoids

2002
Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.
    Journal of medicinal chemistry, 2015, Apr-23, Volume: 58, Issue:8

    Topics: Antineoplastic Agents; Benzoflavones; Cell Line, Tumor; Cytochrome P-450 CYP1B1; Docetaxel; Drug Resistance, Neoplasm; Humans; Molecular Docking Simulation; Neoplasms; Taxoids

2015